Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REFERENCES<br />
Hegde R., Sr<strong>in</strong>ivasula S. M., Zhang Z., Wassell R., Mukattash R., Cilenti L., DuBois G., Lazebnik,<br />
Y., Zervos A. S., Fernandes-Alnemri T. and Alnemri E. S. (2002) Identification <strong>of</strong> Omi/HtrA2<br />
as a mitochondrial apoptotic ser<strong>in</strong>e protease that disrupts <strong>in</strong>hibitor <strong>of</strong> apoptosis prote<strong>in</strong>-<br />
caspase <strong>in</strong>teraction. J. Biol. Chem. 277, 432–438.<br />
Heikkila R. E., Manz<strong>in</strong>o L., Cabbat F. S. and Duvois<strong>in</strong> R. C. (1984) Protection aga<strong>in</strong>st the<br />
dopam<strong>in</strong>ergic <strong>neurotoxicity</strong> <strong>of</strong> 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrid<strong>in</strong>e by<br />
monoam<strong>in</strong>e oxidase <strong>in</strong>hibitors. Nature 311, 467–469.<br />
Heikkila R. E., Nicklas W. J. and Duvois<strong>in</strong> R. C. (1985) Dopam<strong>in</strong>ergic toxicity after the stereotaxic<br />
adm<strong>in</strong>istration <strong>of</strong> the 1-methyl-4-phenylpyrid<strong>in</strong>ium ion (MPP + ) to rats. Neurosci. Lett. 59,<br />
135–140.<br />
Hermida-Ameijeiras A., Méndez-Álvarez E., Sánchez-Iglesias S., Sanmartín-Suárez C. and Soto-<br />
Otero R. (2004) Autoxidation and MAO-mediated metabolism <strong>of</strong> dopam<strong>in</strong>e as a potential<br />
cause <strong>of</strong> <strong>oxidative</strong> <strong>stress</strong>: role <strong>of</strong> ferrous and ferric ions. Neurochem. Int. 45, 103–116.<br />
Hernan M. A., Takkouche B., Caamano-Isorna F. and Gestal-Otero J. J. (2002) A meta-analysis<br />
<strong>of</strong> c<strong>of</strong>fee dr<strong>in</strong>k<strong>in</strong>g, cigarette smok<strong>in</strong>g, and the risk <strong>of</strong> Park<strong>in</strong>son’s disease. Ann. Neurol. 52,<br />
276–284.<br />
Herrera A. J., Castano A., Venero J. L., Cano J. and Machado A. (2000) The s<strong>in</strong>gle <strong>in</strong>tranigral<br />
<strong>in</strong>jection <strong>of</strong> LPS as a new model for study<strong>in</strong>g the selective effects <strong>of</strong> <strong>in</strong>flammatory reactions<br />
on dopam<strong>in</strong>ergic system. Neurobiol. Dis. 7, 429–447.<br />
Hertzman C., Wiens M., Bower<strong>in</strong>g D., Snow B. and Calne D. (1990) Park<strong>in</strong>son's disease: a case-<br />
control study <strong>of</strong> occupational and environmental risk factors. Am. J. Ind. Med. 17, 349–355.<br />
Hess D. T., Matsumoto A., Kim S. O., Marshall H. E., Stamler J. S. (2005) Prote<strong>in</strong> S-nitrosylation:<br />
purview and parameters. Nat. Rev. Mol. Cell Biol. 6, 150–166.<br />
Hilker R., Schweitzer K., Coburger S., et al. (2005) Nonl<strong>in</strong>ear progression <strong>of</strong> Park<strong>in</strong>son disease<br />
as determ<strong>in</strong>ed by serial positron emission tomographic imag<strong>in</strong>g <strong>of</strong> striatal fluorodopa F 18<br />
activity. Arch. Neurol. 62, 378 –382.<br />
203